Видео

Very interesting interview - thank you both.

It would be interesting to have a follow up episode regarding the news of Lanthaler trading in the group's shares

Thank you for the insight and relevant links shared in the description. Good job!

So exciting to have our first episode in front of a live audience! It was really inspiring listening to Lovisa and her journey, as well as the incredible amount of company-building by Flagship Pioneering.

Really cool to be able to talk to Szabi and learn more about Turbine. It really proves that you don't necessarily have to be in a biotech hub to find success 🚀

Going to the moon in 2025? 😄

It was great to be able to learn more about this incredibly important area of TCR cell therapy from such a leader in the field. Thanks so much to Adrian for your inspiration, Adaptimmune for loaning us your CEO for an hour, and Merck for being our first amazing sponsor What part did you find most interesting?

Good job to Merck, who recognizes the value the podcast!

Great insight! Also, thank you for adding more features - chapters and transcription to make it easier for listener to navigate. It is great to have your podcast in Europe to know better biotech field

I really enjoyed talking with Marina. Nouscom is doing great things in the cancer vaccine space and it was super interesting to pick her brain over this!

Wow! Another amazing female CEO - super inspiring!!

💯

💯

WOW! I'm already pretty heavily invested in IMTX but what a fantastic CEO who understands the competitive landscape and patient need very well and has really positioned IMTX to succeed based on that understanding. Great interview - thanks!

I enjoyed talking with Harpreet a lot. After this conversation, I learned a lot about PRAME receptors and TCR therapeutics. I hope you also find it as insightful as I did. Thanks for taking the time to chat with me, Harpreet! 🙏

Very Interesting, thanks for all the insights. Hope to see further innovation and growth at Immatics!

Amazing episode! super insightful

Great to have met Dominik offline and have that conversation. Funny we both started businesses when we were kids 🚀😇

Great episode. Recently, so many biotech are acquired by Pharma. Look forward to hearing more story of all upcoming biotech company!

Great episode, Sander is really inspiring me :)

Gut feeling is synthesized in the brain, genius Jens Nielsen quote

Very inspiring example of a successful female biotech venture capital!

Great fun to talk with Otello in Boston (always good to be back). Enjoy 😀

@flot.bio_ Hello! Cardior has recently withdrawn CDR132L with HFpEF Phase II trial. Will the trial be conducted at all? What does it mean 'Transfer of study responsibility and planning'? Will someone else conduct it? Novo Nordisk? clinicaltrials.gov/study/NCT05953831

Very insightful - I'm enjoying these and am learning lots, keep em coming!

I'm impressed by how good Naveed is at investing and seeing things clearly. Awesome conversation! What do you think?

Thank you for the interview! Do you know when Cardior is planning to run Phase III CDR132L trial? Will they wait until all the Phase II trials are done before running any Phase III trial? If Phase III CDR132L trial is successful will it possible to see CDR132L on the market as soon as possile? or one simple question: When the patients should wait CDR132L to be released on mass market (based on your/her estimation, of course)?

Dr. Rahul Agrawal was the CMO of Cardior. He recently went to Cereno Scientific. "Cereno Scientific (Nasdaq First North: CRNO B) today announced that Dr. Rahul Agrawal has been appointed as Chief Medical Officer and Head of R&D." (2024-02-13)

Keen to learn more about Cardior and Claudia! Congrats for the exit!

Ty Philip. what an epic podcast and ideas illustrated. You made me understand what my father is doing in a normal, non sciency way, so enjoyable ty.

That's my Dad 🎉 such a brilliant mind and intelligent view on everything. You guys need to tell him to chill down on work, he way too hot ❤🔥🔥🥵🥵 🕶️🕶️ always saying 'I'm 3xtremely caught up this season, busy busy busy' and taking months to call back 🧊🧊🥶🥶🏔️🏔️😰 even humans invented the phone 📱 love 💕 u

Great episode! It would be appreciate to hear more about commercial strategy and plan for rare disease across EU and US.

Amazing episode!

Excellent! Thanks for this interview!

Fredriksen alias Elisabeth Holmes Look the same for me They have done this ponansa swindel for 18 year now Who going to stop miss Fredriksen and here people

Inspiring.... again. Thanks for doing this interview.

Great episode!

Wow I see Rodger Novak’s name on the CRSP stock filings but it’s great u got a multiple times successful biotech entrepreneur to talk about his biotech process. His target selection explanation is gold and clued me into how strong management was for this CRSPR company compared to others. Can’t wait to see Mr. Novak’s next project

Excellent interview -- thank you for doing this!

Leider kann man dem Interview nicht folgen, da der Interviewer eine unangenehm angekratzte Stimme hat. Das Transkript, welches zum Nachlesen angeboten wird, müsste redaktionell überarbeitet werden.

Hey Philip, thank you very much for this episode. I really like the idea of "BioLabs" looking forward that there will be more locations in Europe. For Germany, I know that we lack lab space and the state is not able to change the status. Thanks again for the input.

Evotec is a key player for the Drug Developing Industry.

Wow, amazing episode 🙌

Very fruitful! It also gives a glimpse of his career pathway - quite inspiring! Success = hard work + right time